Author: Jefferies, Sarah; Braithwaite, Irene; Walker, Steven; Weatherall, Mark; Jennings, Lance; Luck, Michelle; Barrett, Kevin; Siebers, Robert; Blackmore, Timothy; Beasley, Richard; Perrin, Kyle
                    Title: Randomized controlled trial of the effect of regular paracetamol on influenza infection  Document date: 2015_12_6
                    ID: vj3m50sb_9
                    
                    Snippet: Following randomization the following study assessments were performed: Pernasal flocked swabs (Copan Diagnostics, Murietta, CA, USA) were collected into Universal Transport Medium (Roche Diagnostics, Basel, Switzerland) taken for influenza quantitative viral load reverse transcriptasepolymerase chain reaction (RT-PCR) analysis at Baseline (before the first medication dose), 24 h (Day 1), 48 h (Day 2) and 120 h (Day 5). All baseline samples were .....
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Following randomization the following study assessments were performed: Pernasal flocked swabs (Copan Diagnostics, Murietta, CA, USA) were collected into Universal Transport Medium (Roche Diagnostics, Basel, Switzerland) taken for influenza quantitative viral load reverse transcriptasepolymerase chain reaction (RT-PCR) analysis at Baseline (before the first medication dose), 24 h (Day 1), 48 h (Day 2) and 120 h (Day 5). All baseline samples were tested for the presence of human ribonucleic acid (RNA) to ensure that samples had obtained human tissue; these were positive in all instances. A multiplex polymerase chain reaction (PCR) (Fast-Track Diagnostics, Junglinster, Luxemburg) was also performed on Baseline samples for other respiratory viruses. 24 Additional pernasal swabs were taken for viral culture at Baseline, Day 1 and Day 5. Blood samples were taken for analysis of serum cytokines (tumour necrosis factor α, IFN-γ and interleukin (IL)-6) at Baseline, Day 2 and Day 5. Details of virology methodology and cytokine analysis are provided in Supplementary Appendix S1.
 
  Search related documents: 
                                Co phrase  search for related documents- Baseline analysis and chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9
  - Baseline analysis and respiratory virus: 1, 2
  - Baseline analysis and serum cytokine: 1
  - Baseline analysis and study assessment: 1, 2, 3
  - Baseline analysis and viral load: 1, 2, 3, 4, 5
  - Baseline sample and blood sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  - Baseline sample and chain reaction: 1, 2
  - Baseline sample and respiratory virus: 1
  - Baseline sample and viral load: 1
  - blood sample and chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
  - blood sample and multiplex polymerase: 1
  - blood sample and multiplex polymerase chain reaction: 1
  - blood sample and necrosis factor: 1, 2, 3
  - blood sample and respiratory virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
  - blood sample and study assessment: 1, 2, 3, 4
  - blood sample and viral culture: 1, 2, 3
  - blood sample and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date